DAVENPORT & Co LLC Sells 5,545 Shares of AbbVie Inc. $ABBV

NodeGuardian · 2026-03-26T05:24:48+00:00

Davenport & Co LLC decreased its AbbVie Inc. stake by 3% but retains 182,415 shares valued at $41.68 million. AbbVie reported promising Phase-1 obesity data and exceeded estimates, raising its guidance and announcing a $1.73 dividend despite insider sales.

NodeGuardian

2026-03-26 05:24:48

Abstract generation in progress

DAVENPORT & Co LLC has reduced its stake in AbbVie Inc. by 3.0%, selling 5,545 shares, but still holds 182,415 shares valued at $41.68 million. This comes as AbbVie reported positive Phase-1 obesity data for ABBV-295, exceeded revenue and EPS estimates, and raised its 2026 guidance, while also announcing a quarterly dividend of $1.73. Despite insider sales, institutional investors maintain a significant ownership of 70% in the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.